#CCRTP25 cancer immunotherapy session covering the breadth of anti tumor immunity - immune tolerance incited by lymph node involvement @retickerflynn.bsky.social, cytokine conditioning of T cells - A Kalbasi, and synthetic engineering of cytokine receptors - K Daniels @stanford-cancer.bsky.social

Good morning Redwood City 🌞 Rise and shine to Day 2 of the #CCRTP25 @stanford-cancer.bsky.social Still unbelievable to be colleagues with Dr Ron Levy and see how integrated and committed he is to educating the next generation of cancer researchers

Great 💎s on GI cancers at #CCRTP25 @stanford-cancer.bsky.social @corsello.bsky.social

-drug discovery w better yield from unexpected hits, then subsequently modified
-negative results so important to publish
-environmental factors like weight most likely culprits of young onset colon cancer

So far we have talked about non smoking Asian females (lung cancer) and people in their 30s and 40s (colon cancer) and I’m feeling a bit targeted in the worst way 😂 #CCRTP25 @stanford-cancer.bsky.social

The amazing breath of nicotine products today, with significantly higher amounts of nicotine than cigarettes, covered by keynote speaker Carly Kajiwara from the Halpern-Felsher Lab @stanford-cancer.bsky.social #CCRTP25